Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Mitchell

Showing results (61-70 of 230) with videos related to

Pageof 23
Sort By:
Advances in Pharmacology (San Diego, Calif.)|July 6, 2026
Transient T cell therapiesYudian Xiao, Mingliang Bai, Melgious Jin Yan Ang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2012
E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cellsMichael J Mitchell, Christina S Chen, Varun Ponmudi, et al.
ACS Biomaterials Science & Engineering|September 10, 2019
Nanomaterial Interactions with Human NeutrophilsPaul W Bisso, Stephanie Gaglione, Pedro P G Guimarães, et al.
Human Molecular Genetics|December 29, 2025
Nucleoporin NUP210L and BAF-paralogue BAF-L redundantly ensure nuclear integrity and manchette microtubule organisation in mouse spermatidsMaha Al Dala Ali, Guy Longepied, Nicolas Lévy, et al.
Journal of Visualized Experiments : Jove|February 6, 2023
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic MixingRakan El-Mayta, Marshall S Padilla, Margaret M Billingsley, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 9, 2018
Advances in Biomaterials for Drug DeliveryOwen S Fenton, Katy N Olafson, Padmini S Pillai, et al.
Advanced Drug Delivery Reviews|February 11, 2024
Emerging strategies for nanomedicine in autoimmunityAjay S Thatte, Margaret M Billingsley, Drew Weissman, et al.
Clinical Genetics|December 21, 2023
Spermatozoa in mice lacking the nucleoporin NUP210L show defects in head shape and motility but not in nuclear compaction or histone replacementMaha Al Dala Ali, Guy Longepied, Aurore Nicolet, et al.
Nature Nanotechnology|January 13, 2021
Nanomaterials for T-cell cancer immunotherapyNingqiang Gong, Neil C Sheppard, Margaret M Billingsley, et al.
Nature Protocols|March 10, 2026
Preparation of targeted lipid nanoparticles for precision nucleic acid deliveryHannah C Geisler, Elisa Battistini, Ajay S Thatte, et al.
Pageof 23

Showing results (61-70 of 230) with videos related to

Sort By:
Pageof 23
Advances in Pharmacology (San Diego, Calif.)|July 6, 2026
Transient T cell therapiesYudian Xiao, Mingliang Bai, Melgious Jin Yan Ang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2012
E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cellsMichael J Mitchell, Christina S Chen, Varun Ponmudi, et al.
ACS Biomaterials Science & Engineering|September 10, 2019
Nanomaterial Interactions with Human NeutrophilsPaul W Bisso, Stephanie Gaglione, Pedro P G Guimarães, et al.
Human Molecular Genetics|December 29, 2025
Nucleoporin NUP210L and BAF-paralogue BAF-L redundantly ensure nuclear integrity and manchette microtubule organisation in mouse spermatidsMaha Al Dala Ali, Guy Longepied, Nicolas Lévy, et al.
Journal of Visualized Experiments : Jove|February 6, 2023
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic MixingRakan El-Mayta, Marshall S Padilla, Margaret M Billingsley, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 9, 2018
Advances in Biomaterials for Drug DeliveryOwen S Fenton, Katy N Olafson, Padmini S Pillai, et al.
Advanced Drug Delivery Reviews|February 11, 2024
Emerging strategies for nanomedicine in autoimmunityAjay S Thatte, Margaret M Billingsley, Drew Weissman, et al.
Clinical Genetics|December 21, 2023
Spermatozoa in mice lacking the nucleoporin NUP210L show defects in head shape and motility but not in nuclear compaction or histone replacementMaha Al Dala Ali, Guy Longepied, Aurore Nicolet, et al.
Nature Nanotechnology|January 13, 2021
Nanomaterials for T-cell cancer immunotherapyNingqiang Gong, Neil C Sheppard, Margaret M Billingsley, et al.
Nature Protocols|March 10, 2026
Preparation of targeted lipid nanoparticles for precision nucleic acid deliveryHannah C Geisler, Elisa Battistini, Ajay S Thatte, et al.
Pageof 23